A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: A five‐year follow‐up of a randomized controlled trial,Neurogastroenterology & Motility

当前位置： X-MOL 学术 › Neurogastroenterol. Motil. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: A five‐year follow‐up of a randomized controlled trial
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2020-10-07 , DOI: 10.1111/nmo.14004
Anne Line Engsbro _{1,

2} , Luise M Begtrup _{3,

4} , Peter Haastrup ₄ , Maria Munch Storsveen ₄ , Peter Bytzer ₁ , Jens Kjeldsen ₅ , Ove Schaffalitzky De Muckadell ₅ , Dorte Ejg Jarbøl ₄

Affiliation

Previously, the diagnosis of irritable bowel syndrome (IBS) required exclusion of organic causes by extensive diagnostic testing. Newer guidelines recommend IBS as a positive diagnosis based on symptoms with limited testing. We investigated the long‐term safety and impact on use of health resources of a positive diagnostic strategy compared to a strategy of exclusion in patients with symptoms compatible with IBS.

中文翻译：

对肠易激综合征患者而言，积极的诊断策略是安全的并可以节省内窥镜检查：一项随机对照试验的五年随访

以前，肠易激综合征 (IBS) 的诊断需要通过广泛的诊断测试排除器质性原因。较新的指南推荐 IBS 作为基于有限测试的症状的阳性诊断。我们调查了与 IBS 症状相符的患者的阳性诊断策略与排除策略的长期安全性和对健康资源使用的影响。

更新日期：2020-10-07

点击分享查看原文

点击收藏

阅读更多本刊最新论文